harmacoeconomic feasibility of using the drug upadacitinib in patients with rheumatoid arthritis in the healthcare system of the Russian Federation by A. M. Lila, S. K. Zyryanov, I. N. Dyakov

Subjects: Get full text

Personalization of an anti-cytokine therapy of psoriatic patients by A. A. Kubanov, S. I. Svishchenko

Subjects: Get full text

Pharmacoeconomic analysis of Actemra^® in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov

Subjects: Get full text

Clinical and economic analysis of biologic drugs in treatment of psoriasis by A. A. Kubanov, S. K. Zyryanov, D. Yu. Belousov

Subjects: Get full text